Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
about
Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomasSmall round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface moleculeAbsence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.Epidemiological and clinical characteristics of neuroblastoma in southern iranNeuroblastoma tumour genetics: clinical and biological aspects.Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.Congenital heart disease and neuroblastoma: just coincidence?Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter studyAssociation of age at diagnosis and genetic mutations in patients with neuroblastoma.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma.Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981-2000: a population-based study.Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartmentsImmunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma.Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow.Adult onset of ganglioneuroblastoma of the adrenal gland: case report and review of the literatureUpdate on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines.RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas.Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey".High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomasRadiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.Chronic neuroblastoma.Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies.Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.Adrenal Ganglioneuroblastoma in an Adult: A Rare Case Report.Three-Dimensional Segmentation of the Tumor in Computed Tomographic Images of Neuroblastoma.Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol.Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in GermanyPROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas
P2860
Q21245646-1016A46C-4590-4B0A-9BB2-0F164E8123E1Q24655582-B4B76B1C-036D-4F53-B12A-F5BA24B2D53AQ33410016-8F13E77C-76B7-4178-9795-28691BE7E7A4Q34059963-383DC379-0739-4117-A019-E8F4053C4792Q34234863-C3418DBE-24B1-432F-9FCB-DDA453300869Q34453849-6F30B77A-3C5D-4996-B27A-654F3AF3A94FQ34667915-257F48AA-5C39-4D32-9F5B-FB46D630C4B4Q34988494-3A28F91B-1774-426A-919D-87FE5A74C002Q35544991-6582AE84-3C23-494C-A636-8957E3655F0EQ35798960-0673FF4E-A35E-4B03-8632-68E0579B3512Q35870376-3D438F76-6BDA-4CBC-A0F3-728F3D64B6A9Q36480024-2FA5CA2B-A770-42ED-A9A3-902057BC8CFCQ36525551-9770768D-3174-4A08-B724-3FFF3A948E2CQ36614690-4363B458-DE56-4C4A-A166-BA0BE928B1CEQ36731569-0872480C-4D6A-4E40-9170-9F35F5975253Q36953849-BF27A6E1-0416-4F3E-BB9F-8482A265CE87Q37123462-73B04235-F28F-4F29-8E8C-E94C9C8E84CDQ37154811-AF2A78AA-39C1-4660-8A3C-BE9F1D66AD85Q37315226-9661EDD5-A7DC-4242-B83F-176DD51AD1E8Q37451551-A2206ADA-A53C-4274-AC0D-F353829DB934Q38318142-0922315C-C887-4C5A-9460-0266926AA643Q38588492-F64944F0-0B44-4FCE-A9C7-A3D3F5CF1805Q38801063-8600662F-D0FD-461C-8DBC-EE46FAAF0065Q38853313-ED5DC747-24A7-4EAD-B818-8BB4A981B26AQ39126205-4F5FC202-A708-444B-8BC2-A3CFECF51490Q40227497-93CA686A-7F3D-4959-A728-E31A4F006745Q40309145-3DC9A7C7-28F5-44A9-8FDB-64B41B32E76AQ40696041-D77F283D-1C97-4FBB-9804-4495DBA0492BQ41561035-533DCCE8-DFC0-4040-8DC2-E8A6FAC5EFEDQ41826142-55C57A8C-5234-42C3-A3FB-3FCBDA8C7520Q41885084-BA16C98F-68EC-440F-B055-D4317CCBB467Q44128430-2C192489-16B1-4197-B2C2-0C2BF4B923A1Q53075722-1F0007FA-D5DD-4DEB-9E48-F4E36D1DAD96Q54362742-C8DE392A-2A8E-4C3B-8660-1570D7A8D518Q55099636-FA1A9029-AA43-4263-83E0-EC75A7BF81D8Q55534708-9C53F75B-7CBC-4ECC-B294-A73A55C369F8Q55618874-0BE5D82C-1601-409D-9BE8-D18D6E19D9A1Q57192687-F16F51CE-D79A-4B26-B737-D4F33BE150A1Q57910024-19939EEA-6712-4712-9289-EF74DEDD2AEB
P2860
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Clinical prognostic factors in ...... tudy Group 'Survey' 1982-1992.
@en
type
label
Clinical prognostic factors in ...... tudy Group 'Survey' 1982-1992.
@en
prefLabel
Clinical prognostic factors in ...... tudy Group 'Survey' 1982-1992.
@en
P2093
P1476
Clinical prognostic factors in ...... tudy Group 'Survey' 1982-1992.
@en
P2093
Cotterill SJ
Pearson AD
Pritchard J
P304
P356
10.1016/S0959-8049(00)00058-7
P577
2000-05-01T00:00:00Z